Jump to search

February 2019

Robot-assisted throat cancer surgery gets assist from novel optical device

February 8, 2019

For hard-to-reach tumors at the back of the throat, robots can assist surgeons to remove cancers in a less invasive way. But this high-tech approach has a drawback: the surgeon’s inability to assess through touch whether they’ve been able to get all of the cancer out.

UC Davis Health works to understand cystic fibrosis-related diabetes

February 7, 2019

Endocrinologist John Yoon is working toward understanding the root causes of cystic fibrosis-related diabetes, which becomes more common for cystic fibrosis patients as they age. His research also has potential to help battle all forms of diabetes

Early intervention in autism improves language, IQ and social skills

February 4, 2019

Breakthrough research demonstrating that children with autism as young as 18 months can vastly improve their language, cognition and social skills with an early intervention developed by UC Davis Professor Sally Rogers has been replicated in a major new study.

January 2019

Neuroscience research funding at UC Davis Health among top in nation

January 29, 2019

UC Davis Health neuroscientists are among some of the best funded in the nation, according to data from the National Institutes of Health.

Physician-researchers earn clinical research honors

January 22, 2019

A research study co-authored by UC Davis Health physicians Jonathan Ducore and Adam Giermasz, co-directors of the UC Davis Health Hemophilia Treatment Center has received a national “Top Ten” award by the Clinical Research Forum.

Experimental drug improves eye gaze behavior in fragile X syndrome

January 17, 2019

Researchers at MIND Institute at UC Davis and Rush University Medical Center have found that mavoglurant, an experimental drug known as an mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome (FXS).

Anti-inflammatory compound helps protect against cancer growth

January 14, 2019

When chemotherapy kills cancer cells, the debris of dead and dying cells can lead to inflammation and the surge of more cancerous cells. Newly published research on ovarian cancer, involving an anti-inflammatory compound developed in the Bruce Hammock lab at UC Davis, and tested at Harvard Medical School on mouse models, indicates that the compound not only suppresses inflammation but reduces cancer growth, acting as a “surge protector.”

December 2018

UC Davis Health leads effort to digitize microscope slides for developing artificial intelligence for Alzheimer's disease, other brain disorders

December 27, 2018

When both of Brittany Dugger’s grandmothers were diagnosed with Alzheimer’s disease, it left a lasting impression and desire to better understand how the same clinical diagnosis could produce different symptoms. Now a new grant will help across multiple UC campuses.

New study shows link between second-hand smoke and cardiac arrhythmia

December 26, 2018

Continuous indoor exposure to second-hand tobacco smoke triggers changes in the heart’s electrical activity, known as cardiac alternans, that can predict cardiac arrhythmia and sudden cardiac death, a new study from UC Davis Health researchers shows. The authors believe the study, conducted in mice, suggests that second-hand smoke exposure alters cells that regulate how the heart beats.

300 Blind Mice Uncover Genetic Causes of Eye Disease

December 21, 2018

Hundreds of new genes linked to blindness and other vision disorders have been identified in a screen of mouse strains. Many of these genes are likely important in human eye vision and the results could help identify new causes of hereditary blindness in patients

UC Davis Health partners with Amgen to understand patient decisions, drive design-thinking decisions

December 20, 2018

Researchers from UC Davis Health recently partnered with Amgen Inc. on two projects to better understand the decision-making processes and educational needs of patients, providers and family caregivers to develop solutions that meet the needs of people facing serious illness.

Later-born siblings of children with autism or ADHD are at elevated risk for both disorders

December 10, 2018

Later-born siblings of children with autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) are at elevated risk for both disorders, a new study led by Meghan Miller, assistant professor in the Department of Psychiatry and Behavioral Sciences and at the UC Davis MIND Institute, has concluded. The findings appear today in JAMA Pediatrics.

Five Researchers at UC Davis Health Named in Global Highly Cited Researchers 2018 List

December 3, 2018

Five UC Davis Health researchers were named in the annual Highly Cited Researchers List.